Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Scarcity of Donor Organs for Organ Transplantation
4.2.2 Technological Advancements
4.3 Market Restraints
4.3.1 Expensive Procedures
4.3.2 Risk of Compatibility Issues and Malfunctions
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Artificial Organ
5.1.1.1 Artificial Heart
5.1.1.2 Artificial Kidney
5.1.1.3 Cochlear Implants
5.1.1.4 Other Organ Types
5.1.2 Bionics
5.1.2.1 Ear Bionics
5.1.2.2 Orthopedic Bionic
5.1.2.3 Cardiac Bionics
5.1.2.4 Others


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abiomed Inc
6.1.2 Asahi Kasei Medical Co., Ltd
6.1.3 Baxter International, Inc.
6.1.4 Berlin Heart GmbH
6.1.5 Boston Scientific Corporation
6.1.6 LivaNova PLC
6.1.7 Esko Bionics
6.1.8 Ossur
6.1.9 Getinge AB
6.1.10 Medtronic PLC


7 MARKET OPPORTUNITIES AND FUTURE TRENDS